Showing results (41-50 of 46) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
British Journal of Cancer|June 11, 2008
Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trialsG L Ceresoli, B Castagneto, P A Zucali, et al.British Journal of Cancer|June 12, 2014
Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter surveyG L Ceresoli, F Grosso, P A Zucali, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2018
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over timeG Pasello, G Zago, F Lunardi, et al.ESMO Open|December 4, 2022
Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesotheliomaS Canova, G L Ceresoli, F Grosso, et al.British Journal of Cancer|July 18, 2013
Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesotheliomaG L Ceresoli, P A Zucali, M Mencoboni, et al.British Journal of Cancer|January 14, 2012
Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST)C Boni, M Tiseo, L Boni, et al.Pageof 5